1. Home
  2. BSVN vs EVO Comparison

BSVN vs EVO Comparison

Compare BSVN & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bank7 Corp.

BSVN

Bank7 Corp.

HOLD

Current Price

$58.63

Market Cap

531.3M

Sector

Finance

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$1.53

Market Cap

568.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BSVN
EVO
Founded
2004
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
531.3M
568.6M
IPO Year
2018
2007

Fundamental Metrics

Financial Performance
Metric
BSVN
EVO
Price
$58.63
$1.53
Analyst Decision
Buy
Buy
Analyst Count
3
3
Target Price
★ $63.33
$4.24
AVG Volume (30 Days)
34.4K
★ 80.7K
Earning Date
10-15-2026
11-05-2026
Dividend Yield
★ 2.04%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 2.12
N/A
Revenue
N/A
N/A
Revenue This Year
$10.97
N/A
Revenue Next Year
$54.28
$20.47
P/E Ratio
$27.71
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$38.29
$1.33
52 Week High
$59.04
$4.27

Technical Indicators

Market Signals
Indicator
BSVN
EVO
Relative Strength Index (RSI) 69.33 46.19
Support Level $53.85 $1.50
Resistance Level N/A $1.97
Average True Range (ATR) 1.08 0.05
MACD 0.28 0.02
Stochastic Oscillator 99.34 47.50

Price Performance

Historical Comparison
BSVN
EVO

About BSVN Bank7 Corp.

Bank7 Corp is a full-service commercial bank focused on providing customers with exceptional service and meeting their banking needs through a variety of commercial and retail financial services. It offers deposit banking products, including commercial deposit services, commercial checking, money market, and other deposit accounts, and retail deposit services such as certificates of deposit, money market accounts, checking accounts, negotiable order of withdrawal accounts, savings accounts, and automated teller machine access. etc. It generates revenues from interest income from financial instruments and non-interest income and service charges on deposit accounts.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: